Molbio Diagnostics
656Rapid point-of-care molecular diagnostics
Healthtech
Established Company
Diagnostics
Active
Founded
2000
Team Size
300
Total Funding
₹150 Cr
Valuation
₹500 Cr
About
Point-of-care molecular diagnostics company. Its Truenat platform became India's first indigenous RT-PCR device for COVID-19 testing. Serves labs across India and Africa.
Funding Snapshot
Free preview
₹100 Cr
Total Raised
1
Round
Series A
Latest · 2022-06-15
Backed by
Temasek
Unlock the full funding history below — every round's amount, valuation & investors.
Funding History
Series A
2022-06-15
₹100 Cr
Lead: Temasek
Investors
Temasek
Details
Financial Metrics
Funding Rounds
1
VedAI Score
656/1000
Developing
Molbio Diagnostics
Healthtech